RECRUITING

The Genetics and Functional Basis of Inherited Platelet, White Blood Cell, Red Blood Cell, and Blood Clotting Disorders.

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Blood contains red blood cells, white blood cells, and platelets, as well as a fluid portion termed plasma. We primarily study blood platelets, but sometimes we also analyze the blood of patients with red blood cell disorders (such as sickle cell disease), white blood cell disorders, and disorders of the blood clotting factors found in plasma. Blood platelets are small cell fragments that help people stop bleeding after blood vessels are damaged. Some individuals have abnormalities in their blood platelets that result in them not functioning properly. One such disorder is Glanzmann thrombasthenia. Most such patients have a bleeding disorder characterized by nosebleeds, gum bleeding, easy bruising (black and blue marks), heavy menstrual periods in women, and excessive bleeding after surgery or trauma. Our laboratory performs advanced tests of platelet function and platelet biochemistry. If we find evidence that a genetic disorder may be responsible, we analyze the genetic material (DNA and RNA) from the volunteer, and when possible, close family members to identify the precise defect.

Official Title

Studies of Interactions Among Normal and Abnormal Blood Cells, and the Vessel Wall, and Studies of Genetic and Functional Basis of Inherited Platelet, White Blood Cell, Red Blood Cell and Coagulation Disorders

Quick Facts

Study Start:2005-09
Study Completion:2024-06
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT00230165

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:Not specified
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Normal healthy volunteers
  2. 2. 18 years of age or older
  3. 3. Either sex
  4. 4. Any ethnic background.
  5. 1. Adults and children
  6. 2. Either sex
  7. 3. Any ethnic background
  1. 1. For studies of platelets that may be affected by anti-platelet therapy, ingestion of aspirin or similar medication in the past week.
  2. 2. Having given blood in the last 8 weeks such that the current donation would exceed a total of 250 ml for the 8 week period.
  3. 3. Having given blood in the past week such that this donation would result in more than 2 donations in one week.
  4. 1. For studies of platelets that may be affected by antiplatelet therapy, ingestion of aspirin or similar medication in the past week
  5. 2. If the patient is known to have a hematocrit ≥25 (assay performed in past 3 months), the same blood drawing criteria as in A, with the addition that for children less than 18 years of age, the maximum amount of blood allowed to be donated in an 8 week period is the lesser of 50 ml or 3 ml/kg.
  6. 3. If the patient has a hematocrit \<25 or if the hematocrit is unknown, the blood drawing limit is the lesser of 20 ml or 1 ml/kg in any 8 week period.

Contacts and Locations

Study Contact

Recruitment Specialist
CONTACT
1-800-782-2737
rucares@rockefeller.edu

Principal Investigator

Barry Coller, MD
PRINCIPAL_INVESTIGATOR
Rockefeller University

Study Locations (Sites)

Rockefeller University Hospital
New York, New York, 10021
United States

Collaborators and Investigators

Sponsor: Rockefeller University

  • Barry Coller, MD, PRINCIPAL_INVESTIGATOR, Rockefeller University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2005-09
Study Completion Date2024-06

Study Record Updates

Study Start Date2005-09
Study Completion Date2024-06

Terms related to this study

Keywords Provided by Researchers

  • Platelets
  • Erythrocytes
  • Leukocytes
  • Coagulation
  • Thrombosis

Additional Relevant MeSH Terms

  • Glanzmann Thrombasthenia